SCHEMBL18540671

SCHEMBL18540671

CSC(C)c1cn(C)c2ncc(F)c(F)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18540756 0.84 — —
SCHEMBL18540668 0.73 — —
SCHEMBL18540748 0.70 LRRK2 (0.30) —
SCHEMBL18538045 0.69 ALOX5AP (0.31) —
SCHEMBL18527234 0.61 RORC (0.31) —
SCHEMBL15341896 0.59 REN (0.33) —
SCHEMBL18540669 0.57 HTR1A (0.31) —
SCHEMBL21094824 0.57 CES2 (0.39) —
SCHEMBL21216516 0.57 RPS6KA3 (0.41) —
SCHEMBL18540670 0.56 KCNH2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050980-A1 OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF DENALI THERAPEUTICS, INC. 2017-02-23 — — US disclosed
Send feedback